Announcements Trials
Browse Landscape

Status

Completed 15Unknown 2Active not recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 518Breast Neoplasms 461Lung Neoplasms 256Prostatic Neoplasms 235Colorectal Neoplasms 218Carcinoma, Non-Small-Cell Lung 188Pancreatic Neoplasms 157Stomach Neoplasms 140Carcinoma, Hepatocellular 136Ovarian Neoplasms 120Multiple Myeloma 98Melanoma 95Head and Neck Neoplasms 95Esophageal Neoplasms 94Urinary Bladder Neoplasms 87Disease 87Lymphoma 79Uterine Cervical Neoplasms 78Hematologic Neoplasms 77Liver Neoplasms 76Brain Neoplasms 76Endometrial Neoplasms 73Neoplasm Metastasis 65Leukemia, Myeloid, Acute 65Colonic Neoplasms 61Rectal Neoplasms 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Leukemia 54Sarcoma 53Glioma 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Observational × Condylomata Acuminata × Clear all
NCT05371353 2024-04-17

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Shanghai Bovax Biotechnology Co., Ltd.

Recruiting
600 enrolled
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡